Tuhura Biosciences, Inc/nv Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, revealing a 4.44% beneficial ownership stake in TuHURA Biosciences Inc. as of September 30, 2025.
NASDAQ
KP Biotech Group LLC has disclosed a 0.9% beneficial ownership stake in TuHURA Biosciences, Inc., holding 447,232 shares of common stock.
NASDAQ
CA Patel F&F Investments, LLC has reported a passive beneficial ownership of 0.9% in TuHURA Biosciences, Inc., holding 447,232 shares of common stock.
NASDAQ
The Vanguard Group has reported a 5.11% beneficial ownership stake in TuHURA Biosciences Inc., holding 2,234,240 shares of common stock.